drugset / Trial / NCT02562417

Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex

NCT02562417 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Sugammadex is used as a reversal drug for rocuronium- or vecuronium-induced neuromuscular block during general anaesthesia. IV dexamethasone is injected as a prophylactic measure against postoperative nausea and vomiting. Recent animal data have shown that dexamethasone may impair the reversal effect of sugammadex. The objective of this randomised controlled trial is to confirm in the clinical practice these preliminary results.

Timeline

Start
2016-06
Primary completion
2018-05
Completion
2018-05

Outcome

Outcome not reported

Stopped: “Change of practice in the department”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 mg/kg Intravenous

Indications

No indication recorded.